The New York-based firm is scrutinizing the sale of Integer Holdings Corporation to KKR for $127.00 per share, alongside Beazer Homes USA’s agreement to be acquired by Dream Finders Homes for $33.50 in cash per share. Additionally, the firm is reviewing the stock-for-stock merger between Supernus Pharmaceuticals and Indivior Pharmaceuticals, which involves an exchange ratio of 1.5401 Indivior shares for each Supernus share held.
Halper Sadeh attorneys argue that these proposed agreements may contain restrictive terms that stifle superior competing offers while potentially favoring insiders over public investors. The firm is currently evaluating whether to pursue litigation to secure increased compensation or mandate further corporate disclosures. Investors involved in these companies are being invited to review their legal options regarding these transactions, which the firm is handling on a contingent fee basis.
Comments (0)
No comments yet. Be the first!